Clinical resource

Pancreas definitive/neoadjuvant EBRT chemoradiation (eviQ ID 3581)

eviQ, Cancer Institute NSW

View Source Source Verified

DoseLab summary

Endorsed eviQ protocol for conventionally fractionated chemoradiation of unresectable or borderline resectable pancreatic cancer. It recommends breath-hold CT (or 4DCT when breath hold isn't feasible), IV contrast, optional fiducial markers, and PET, CT or MRI to aid tumor delineation — noting that adequate image fusion may be difficult. The target is the gross tumor and involved nodes only. Its organ table covers the bowel, duodenum, stomach, heart, kidneys, liver and spinal cord.

Why this is useful

A conventionally fractionated pancreas protocol covering breath-hold simulation, fiducials, image fusion and an upper-abdominal organ table (bowel, duodenum, stomach, kidneys, liver, cord).

Reference details

Title
Pancreas definitive/neoadjuvant EBRT chemoradiation (eviQ ID 3581)
Authors / organization
eviQ, Cancer Institute NSW
Publication / protocol
eviQ Radiation Oncology protocol 3581
Version
v.4 — last reviewed 14 June 2024; review due 30 June 2028
Year
2024
DOI
Pending verification
Disease sites
GI
Topics
Pancreas, Conventional fractionation, Motion, Breath hold, Dose Constraints, Protocols
Fractionation context
50.4–54 Gy / 28–30 fx (unresectable); 45–50.4 Gy / 25–28 fx (borderline resectable)
Last reviewed by DoseLab
2026-09-29

Cited on DoseLab